Semaglutide and the GLP-1 Wave: The Investment Thesis Behind Pharma's Biggest Boom
A deep dive into semaglutide (Ozempic, Wegovy) for investors: what it is, the problem it solves, how Novo Nordisk built a $30bn franchise, the Lilly duopoly, and which Indian companies stand to win as the patent expires.
